Phase II Trial of Immunonutrition in Hepatectomy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorTata Memorial Centre
About this trial
A randomised open labelled study to evalaute the impact of immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors
Eligibility criteria
Qualifiers
Patients with liver tumors planned for major hepatectomies (defined as resection of >/= 3 liver segments)
Age above 18 years
ASA class I-III
Disqualifiers
Preoperative severe renal failure (estimated glomerular filtration rate < 30 ml/min)
History of hypersensitivity to arginine, omega-3 fatty acids, or nucleotide 3. Inability to take oral nutrition
Trial design
Treatments tested in this trial
- Immunonutrition
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov